Enovis Corp
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold… Read more
Enovis Corp (ENOV) - Total Assets
Latest total assets as of September 2025: $4.43 Billion USD
Based on the latest financial reports, Enovis Corp (ENOV) holds total assets worth $4.43 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Enovis Corp - Total Assets Trend (2004–2024)
This chart illustrates how Enovis Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Enovis Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Enovis Corp's total assets of $4.43 Billion consist of 24.3% current assets and 75.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.0% |
| Accounts Receivable | $407.03 Million | 8.6% |
| Inventory | $547.12 Million | 11.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.32 Billion | 27.9% |
| Goodwill | $1.69 Billion | 35.9% |
Asset Composition Trend (2004–2024)
This chart illustrates how Enovis Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Enovis Corp's current assets represent 24.3% of total assets in 2024, an increase from 0.0% in 2004.
- Cash Position: Cash and equivalents constituted 1.0% of total assets in 2024, up from 0.0% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is goodwill at 35.9% of total assets.
Enovis Corp Competitors by Total Assets
Key competitors of Enovis Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Enovis Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Enovis Corp generates 0.45x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Enovis Corp is currently not profitable relative to its asset base.
Enovis Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.22 | 2.27 | 1.68 |
| Quick Ratio | 1.16 | 1.12 | 0.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $704.68 Million | $ 672.84 Million | $ 550.17 Million |
Enovis Corp - Advanced Valuation Insights
This section examines the relationship between Enovis Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.62 |
| Latest Market Cap to Assets Ratio | 0.27 |
| Asset Growth Rate (YoY) | 4.6% |
| Total Assets | $4.72 Billion |
| Market Capitalization | $1.26 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Enovis Corp's assets below their book value (0.27 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Enovis Corp's assets grew by 4.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Enovis Corp (2004–2024)
The table below shows the annual total assets of Enovis Corp from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.72 Billion | +4.64% |
| 2023-12-31 | $4.51 Billion | +5.52% |
| 2022-12-31 | $4.27 Billion | -49.82% |
| 2021-12-31 | $8.52 Billion | +15.84% |
| 2020-12-31 | $7.35 Billion | -0.48% |
| 2019-12-31 | $7.39 Billion | +11.86% |
| 2018-12-31 | $6.60 Billion | -1.75% |
| 2017-12-31 | $6.72 Billion | +5.26% |
| 2016-12-31 | $6.39 Billion | -5.16% |
| 2015-12-31 | $6.73 Billion | -7.07% |
| 2014-12-31 | $7.25 Billion | +10.06% |
| 2013-12-31 | $6.58 Billion | +7.39% |
| 2012-12-31 | $6.13 Billion | +463.11% |
| 2011-12-31 | $1.09 Billion | +6.50% |
| 2010-12-31 | $1.02 Billion | +1.89% |
| 2009-12-31 | $1.00 Billion | +9.86% |
| 2008-12-31 | $913.08 Million | +1.84% |
| 2007-12-31 | $896.54 Million | +12.46% |
| 2006-12-31 | $797.23 Million | +13.80% |
| 2005-12-31 | $700.57 Million | -1.03% |
| 2004-12-31 | $707.88 Million | -- |